Earlier today, I
wrote that investors in DTS Inc. would likely be happy to learn
about a note in Zoran Corporation's 10-Q filing stating that they
incurred an 11 million expense "in connection with settlement of
various intellectual property disputes." I also noted that
that in looking through many Zoran reports, I could not find any
other instance of intellectual property disputes or settlements for
Zoran Corporation, suggesting the full 11 million probably went to
DTS.
But get this. DTS today on their earnings call refused to
give the actual settlement amount, noting the terms of their
settlement agreement with Zoran. What's worse is they seemed
to have missed previous non-GAAP expectations and are masking it by
only offering GAAP numbers.
On the call last quarter, Jon Kirchner, DTS' CEO stated, "We
essentially have for the purposes of keeping everybody on an
apples-to-apples kind of comparison basis, [the Zoran lawsuit has]
been excluded - both the expenses as well as any potential
financial recovery that might stem from it."
On today's call, there was no "apples-to-apples kind of
comparison," as promised. Instead management offered a few
pieces of information from their 10-Q and press release. On
their press release, DTS states, "Excluding the settlement of
litigation matters, adjusted revenues were in excess of $14 million
for the second quarter of 2009."
That suggests the Zoran corporation settlement was around 10
million, not 11 million.
In their May call, executives offered non-GAAP eps guidance of
.55-.60 and revenue of 65-69 million. Their non-GAAP guidance
only excluded the Zoran expenses and the potential settlement. The
expenses for the settlement were 8.725 million in the past two
quarters, according to today's 10-Q. If we assume a 10
million dollar settlement, that's a gain of 1.275 million or .07 a
share. Management "adjusted" their GAAP guidance (which they
never gave previously) to .57-.62 on 76-79 million, translating
into 10.5 million more revenue and .02 more in eps.
So assuming that the settlement was for 10 million, that means
they are actually raising the year's revenue guidance by .5 million
and reducing full year guidance by .05
Management sounded very positive in their conference call about
this. Shares seemed to fall in the after hours. Nice
try guys.
(I'm actually still wondering what happened to the other 1
million from the Zoran filing. If the 11 million figure was
correct, that would actually make it an .11 guidance miss for the
year. But no worries. No reason not to trust these guys
after they just went from GAAP to non-GAAP back to GAAP.)